Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2012 Feb;76(2):228–235. doi: 10.1111/j.1365-2265.2011.04187.x

Figure 3.

Figure 3

A. Relation between plasma NTproCNP at baseline and deviation in bone age from chronological age (Δ bone age) in hypo- (filled symbols) and hyperthyroid subjects (open symbols). B. Relation between change from baseline in plasma NTproCNP at 1 mo of treatment (Δ) and deviation in bone age from chronological age in hypo- (filled symbols) and hyperthyroid subjects (open symbols). Regression lines were derived by the method of least squares.